NCT05414500 2025-08-08
Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides
University of Alabama at Birmingham
Phase 1 Recruiting
Clinical Trials
3 trialsNCT02822586 2019-08-30
TSEB and Brentuximab for Treatment of Mycosis Fungoides & Sezary Syndrome
Virginia Commonwealth University
Phase 1 Completed
NCT03373305 2019-04-30
Brentuximab Vedotin and Lenalidomide in Treating Patients With Relapsed or Refractory T-Cell Lymphomas
City of Hope Medical Center
Phase 1 Withdrawn